eters such as ejection fraction (LVEF) and internal diameter at diastole index corrected by BSA (LVEDDI). In total, 128 LV proteins were identified to be significantly (p<0.05) associated with LVEF, and 101 with LVEDDI presenting an overlap of 60% common proteins. All significantly associated proteins with mitochondrial localization and metabolic function showed lower abundance with impaired myocardial function. The majority of proteins with negative association to LVEF were assigned to structural components of cardiac tissue, RNA metabolism or proteins of the extracellular space. With loss of cardiac function, low protein levels were observed for muscle glycogen phosphorylase (PYGM) and mitochondrial complex III proteins, whereas high protein levels were found for collagen I, apolipoprotein D and the acute phase response protein S100A9. Conclusion: Impaired LV myocardial function is accompanied by alterations of LV proteins related to energy production, extracellular microfibrills, thin actin filaments, RNA metabolism and acute phase response, highlighting proteins involved in immune modulation and glycogen metabolism as indicators for LV dysfunction. Acknowledgement/Funding: This work was supported by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research). Background: Cardiac toroponin T (cTnT) is one of the biomarkers reflecting myocardial injury widely used for the diagnosis of acute coronary syndrome. Recent reports suggested that, in non-ischemic cardiomyopathy as well, cTnT elevation occurs in patients with heart failure, serving as a potent predictor of adverse outcome. However, the background mechanisms accounting for cTnT elevation in this population has not been clarified. Method: We included consecutive patients who diagnosed with DCM after inpatient examination including echocardiography and cardiac catheterization between 2011 and 2014 (36 female, mean 53±14 years). Diagnosis of DCM was based on left ventricular ejection fraction (LVEF) <45%, no significant coronary disease, and exclusion of secondary cardiomyopathy such as sarcoidosis and amyloidosis with endomyocardial biopsy. We also excluded patients with renal dysfunction (serum creatinine >3.0mg/dL) from this analysis. Highsensitive cTnT (hs-cTnT) assay was performed in 114 patients who were consequently included in this study. Demographic, laboratory, echocardiographic data, as well as hemodynamic data and survival data, were collected from the patients' medical records. We calculated LV end-diastolic wall stress (LV EDWS) by using echocardiographic and hemodynamic data based on the following equation: EDWS=(0.334*(LV end-diastolic pressure)*(LV end-diastolic dimension)/(posterior wall thickness)*(1+(posterior wall thickness)/(LV end-diastolic dimension). We studied the association between hs-cTnT and survival, echocardiographic and hemodynamic data including LV EDWS. Results: Serum hs-cTnT was ranged 0.003-0.124 ng/mL (mean 0.017±0.019 ng/mL). The values of log hs-TnT was positively correlated with LVEDP (r=0.41, p<0.0001), mean PAP (r=0.48, p<0001) and LV EDWS (r=0.31, p=0.0038). Based on receiver operating characteristic analysis, patients were divided into two groups: high TnT group (hs-cTnT ≥0.017 ng/mL) and low TnT group (hs-cTnT <0.017 ng/mL). High TnT group showed higher LVEDP (15±7 vs. 10±6 mmHg, p=0.002), mean PAP (21.9±8.2 vs. 15.7±6.1 mmHg, p<0.0001) and higher LV EDWS (36.5±27.2 vs. 23.7±16.7 kdynes/cm 2 , p=0.02) levels compared to low TnT group, despite comparable cardiac index (2.9±0.8 vs. 3.0±0.6 L/min/m 2 , p=0.27). In survival analysis, high TnT group had worse composite outcome determined by death, LVAS implantation, appropriate ICD discharge, ischemic stroke, and heart failure hospitalization compared to low hs-TnT group (log-rank p=0.003, Figure) . Conclusions: Patients with high cTnT level had poor outcome in DCM. Elevation of cTnT concentration was strongly associated with worse hemodynamic status including increased LV EDW. Our results suggest that ongoing myocardial injury would be, at least in part, caused by elevated LV wall stress, accounting for poor clinical outcome in patients with increased hs-cTnT level in DCM. Purpose: We aimed to determine the prognostic value of electrocardiogram (ECG) in the occurrence of adverse outcomes in patients with idiopathic or familial DCM. Methods: Multicentric study of consecutive patients with familial DCM (≥1 family member with DCM or a first-degree relative with unexplained sudden death <35 year) and patients under 50 years with idiopathic DCM, followed at referral centres. Patients underwent extensive clinical evaluation, ECG, 24h-Holter, echocardiogram and cardiac MRI evaluation, when feasible, and molecular analysis. Only patients with follow-up data were included. Assessment of vital status, heart transplantation (HT) and cardiac-related hospitalizations were registered. Results: We included 99 patients, 59 (60%) male, mean age at diagnosis 38±13 years, mean left ventricle (LV) ejection fraction 34±12% and LV end-diastolic diameter 63±8 mm. Forty-five (46%) patients presented criteria of fDCM (corresponding to 37 families) and 46 (51%) were in NYHA class I. After a median follow-up of 28 (IQR 18) months, 14 (14%) patients experienced adverse events (composite of death, HT and hospitalization from cardiac causes). Kaplan-Meyer survival analysis showed that sinus rhythm (p<0.001), atrial fibrillation (p=0.041), first-degree atrioventricular block (AVB) (p<0.001) and nonsustained ventricular tachycardia (NSVT) (p=0.003) significantly influenced survival without adverse events (Graphs 1-4). Multivariate logistic revealed NSVT as an independent predictor of worse outcome (OR 16.3; p=0.016).
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Background: Cardiac toroponin T (cTnT) is one of the biomarkers reflecting myocardial injury widely used for the diagnosis of acute coronary syndrome. Recent reports suggested that, in non-ischemic cardiomyopathy as well, cTnT elevation occurs in patients with heart failure, serving as a potent predictor of adverse outcome. However, the background mechanisms accounting for cTnT elevation in this population has not been clarified. Method: We included consecutive patients who diagnosed with DCM after inpatient examination including echocardiography and cardiac catheterization between 2011 and 2014 (36 female, mean 53±14 years). Diagnosis of DCM was based on left ventricular ejection fraction (LVEF) <45%, no significant coronary disease, and exclusion of secondary cardiomyopathy such as sarcoidosis and amyloidosis with endomyocardial biopsy. We also excluded patients with renal dysfunction (serum creatinine >3.0mg/dL) from this analysis. Highsensitive cTnT (hs-cTnT) assay was performed in 114 patients who were consequently included in this study. Demographic, laboratory, echocardiographic data, as well as hemodynamic data and survival data, were collected from the patients' medical records. We calculated LV end-diastolic wall stress (LV EDWS) by using echocardiographic and hemodynamic data based on the following equation: EDWS=(0.334*(LV end-diastolic pressure)*(LV end-diastolic dimension)/(posterior wall thickness)*(1+(posterior wall thickness)/(LV end-diastolic dimension). We studied the association between hs-cTnT and survival, echocardiographic and hemodynamic data including LV EDWS. Results: Serum hs-cTnT was ranged 0.003-0.124 ng/mL (mean 0.017±0.019 ng/mL). The values of log hs-TnT was positively correlated with LVEDP (r=0.41, p<0.0001), mean PAP (r=0.48, p<0001) and LV EDWS (r=0.31, p=0.0038). Based on receiver operating characteristic analysis, patients were divided into two groups: high TnT group (hs-cTnT ≥0.017 ng/mL) and low TnT group (hs-cTnT <0.017 ng/mL). High TnT group showed higher LVEDP (15±7 vs. 10±6 mmHg, p=0.002), mean PAP (21.9±8.2 vs. 15.7±6.1 mmHg, p<0.0001) and higher LV EDWS (36.5±27.2 vs. 23.7±16.7 kdynes/cm 2 , p=0.02) levels compared to low TnT group, despite comparable cardiac index (2.9±0.8 vs. 3.0±0.6 L/min/m 2 , p=0.27). In survival analysis, high TnT group had worse composite outcome determined by death, LVAS implantation, appropriate ICD discharge, ischemic stroke, and heart failure hospitalization compared to low hs-TnT group (log-rank p=0.003, Figure) . Conclusions: Patients with high cTnT level had poor outcome in DCM. Elevation of cTnT concentration was strongly associated with worse hemodynamic status including increased LV EDW. Our results suggest that ongoing myocardial injury would be, at least in part, caused by elevated LV wall stress, accounting for poor clinical outcome in patients with increased hs-cTnT level in DCM. Background: The natural history of patients with dilated cardiomyopathy (DCM) is variable and clinical parameters are poor predictors of clinical outcome. Purpose: We aimed to determine the prognostic value of electrocardiogram (ECG) in the occurrence of adverse outcomes in patients with idiopathic or familial DCM. Methods: Multicentric study of consecutive patients with familial DCM (≥1 family member with DCM or a first-degree relative with unexplained sudden death <35 year) and patients under 50 years with idiopathic DCM, followed at referral centres. Patients underwent extensive clinical evaluation, ECG, 24h-Holter, echocardiogram and cardiac MRI evaluation, when feasible, and molecular analysis. Only patients with follow-up data were included. Assessment of vital status, heart transplantation (HT) and cardiac-related hospitalizations were registered. Results: We included 99 patients, 59 (60%) male, mean age at diagnosis 38±13 years, mean left ventricle (LV) ejection fraction 34±12% and LV end-diastolic diameter 63±8 mm. Forty-five (46%) patients presented criteria of fDCM (corresponding to 37 families) and 46 (51%) were in NYHA class I. After a median follow-up of 28 (IQR 18) months, 14 (14%) patients experienced adverse events (composite of death, HT and hospitalization from cardiac causes). Kaplan-Meyer survival analysis showed that sinus rhythm (p<0.001), atrial fibrillation (p=0.041), first-degree atrioventricular block (AVB) (p<0.001) and nonsustained ventricular tachycardia (NSVT) (p=0.003) significantly influenced survival without adverse events (Graphs 1-4). Multivariate logistic revealed NSVT as an independent predictor of worse outcome (OR 16.3; 95% CI 1.7-158.3, p=0.016). Conclusions: In our cohort of DCM patients, 14% experienced an adverse event. Simple ECG data, namely atrial fibrillation, first-degree AVB and NSVT, may help to identify patients at higher risk of worse outcome, whom might beneficiate from a more aggressive clinical vigilance and timely interventions.
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